Brochure
8 Jun 2026

WuXi Biologics Capabilities Overview

PDF 2.4 MB

As a leading CRDMO, WuXi Biologics integrates biologics services from concept through commercialization, delivering quality at every stage. We perform under the most demanding conditions, advancing programs at unmatched speed with expertise and assurance. Multi-modality discovery generates development-ready assets built for continuity. A growing pipeline supports over 660 IND approvals and25 commercial manufacturing programs. DNA reaches IND in as little as 6 months.

Content provided by our supplier

WuXi Biologics USA LLC

  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Animal Health
Contract Manufacturer
Pharmaceutical Company (innovator finished products)

Other Content from WuXi Biologics USA LLC ()